Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-07-000324
Filing Date
2007-02-14
Accepted
2007-02-14 17:32:12
Documents
1
Group Members
LEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLCMAVERICK CAPITAL, LTD.

Document Format Files

Seq Description Document Type Size
1 sc13g_021407-trubionpharma.txt SC 13G 17505
  Complete submission text file 0000947871-07-000324.txt   19512
Mailing Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201
Business Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

EIN.: 000000000
Type: SC 13G

Mailing Address 2401 14TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 14TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Subject) CIK: 0001298521 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-82147 | Film No.: 07623164
SIC: 2834 Pharmaceutical Preparations